This regenerative medicine program involves the injection of iPS cell-derived exosomes into the knee joint, with the goal of supporting the management of inflammation and the maintenance of joint function.

The iPS Cell-Derived Exosome Knee Injection Program is attracting attention as an emerging approach in the field of regenerative medicine. By delivering iPS cell-derived exosomes directly into the knee joint, the program is intended to support inflammation management and help maintain joint function in individuals experiencing age-related discomfort, joint stress, or reduced mobility.

At our clinic, we integrate perspectives from regenerative medicine, functional medicine, and preventive medicine to provide personalized recommendations tailored to each patient's condition, lifestyle, and goals. We frequently receive consultations from individuals who wish to maintain independent mobility for as long as possible or continue participating in sports and recreational activities.

We place strong emphasis on pre-treatment consultation with the attending physician and maintain a clinical framework designed with careful consideration for both safety and continuity of care.

Support is available in Japanese, Chinese, and English, enabling us to assist both domestic and international patients. Our goal is to provide an environment where patients can seek consultation with confidence and explore advanced regenerative medicine options in a safe and supportive setting.

Providing Medical Institution

JTK clinic

〒102-0083
2nd Floor, Kojimachi Shimura Building, 4-1-5 Kojimachi, Chiyoda-ku, Tokyo

https://www.jtkclinic.com/

Specialty

(Disease) Chronic Pain, Fibromyalgia
(Disease) Lifestyle-Related Diseases (Hypertension, Diabetes Mellitus, Dyslipidemia)
(Disease) Selected Autoimmune Diseases (e.g., Systemic Lupus Erythematosus)
(Disease) Various Solid Tumors
(Therapy / Procedure) Blood Purification Therapy Using LDL Apheresis (for Hypercholesterolemia and Atherosclerosis)
(Therapy / Procedure) Immune Cell Infusion Therapy (for Various Solid Tumors)
(Therapy / Procedure) Stem Cell Therapy (for Chronic Pain)　
(Treatment / Procedure)iPS Cell-Derived Exosome Therapy (Intravenous Infusion, Intranasal Administration, Intra-Articular Knee Injection, and Inhalation Therapy)　　　　　　　　　　　

Eligibility Criteria/Exclusions for Treatment

Our clinic is barrier-free; however, access from the building entrance to our clinic on the 2nd floor is available only via stairs.

Wheelchair users may access the elevator from the basement level (B1F). However, as our staff must prepare a portable ramp and provide assistance while guiding the wheelchair, advance consultation is required.

We appreciate your understanding and cooperation.

Remarks

Duration

Approximately 60 minutes

Treatment Process
Patient identity verification
Body temperature measurement
Completion of a medical questionnaire
Medical consultation and treatment explanation
Completion and signing of the informed consent form
Treatment procedure
Contraindications / Cases Requiring Medical Consultation

Patients with the following conditions may not be eligible for treatment or may require prior medical assessment:

Pregnant individuals (subject to medical consultation)
Individuals with a history of cancer or current cancer diagnosis (subject to medical consultation)

Precautions / Contraindications

Patients Who May Not Be Eligible for Treatment or Require Prior Medical Consultation
Pregnant individuals
Patients currently undergoing cancer treatment or those who have previously received cancer treatment
Knee injection therapy is available only on days when a physician qualified to perform intra-articular knee injections is on duty. Appointment scheduling and treatment dates must therefore be arranged in advance.